European Journal of Medicinal Chemistry

Eur J Med Chem · ISSN (print) 0223-5234 · ISSN (e) 1768-3254 · 10 papers in corpus
2023
doi:10.1016/j.ejmech.2023.115476 ·PMID:37207534

The objective of this review is to provide an update on the fluorine-containing drugs approved by U.S. Food and Drug Administration in the span of past five years (2018-2022). The agency accepted a total of fifty-eight fluorinated entities …

review 2020
doi:10.1016/j.ejmech.2019.111951 ·PMID:31821990

Gynaecological disorders, such as cervical, ovarian, and endometrial cancers are the second most prevalent cancer types in women worldwide. Therapeutic approaches for gynaecological cancers involve chemotherapy, radiation, and surgery. Howe…

other 2019
doi:10.1016/j.ejmech.2019.05.084 ·PMID:31176098

Estrogens are the major female sex steroid hormones, estradiol (E2) being the most potent form in humans. Disturbing the balance between E2 and its weakly active oxidized form estrone (E1) leads to diverse types of estrogen-dependent diseas…

2019
doi:10.1016/j.ejmech.2018.10.023 ·PMID:30347329

c-Jun N-terminal kinases (JNKs) play a central role in many physiologic and pathologic processes. We synthesized novel 11H-indeno[1,2-b]quinoxalin-11-one oxime analogs and tryptanthrin-6-oxime (indolo[2,1-b]quinazoline-6,12-dion-6-oxime) an…

other 2017
doi:10.1016/j.ejmech.2016.11.004 ·PMID:27852458

Current endocrine therapeutics for the estrogen-dependent disease endometriosis often lead to considerable side-effects as they act by reducing estrogen action systemically. A more recent approach takes advantage of the fact that the weak e…

other 2015
doi:10.1016/j.ejmech.2015.08.030 ·PMID:26322835

17β-Estradiol (E2), the most potent human estrogen, is known to be involved in the etiology of estrogen-dependent diseases (EDD) like breast cancer and endometriosis. 17β-Hydroxysteroid dehydrogenase type 1 (17β-HSD1) catalyses the last ste…

other 2014
doi:10.1016/j.ejmech.2014.05.074 ·PMID:24929290

Estradiol is the most potent estrogen in humans. It is known to be involved in the development and proliferation of estrogen dependent diseases such as breast cancer and endometriosis. The last step of its biosynthesis is catalyzed by 17β-h…

2011
doi:10.1016/j.ejmech.2011.03.030 ·PMID:21481497

In a continuing effort to improve the subtype selectivity and agonist potency of estrogen receptor β (ERβ) ligands, we have designed and developed a thus far unexplored structural series obtained by molecular refinements of monoaryl-substit…

article 2009
doi:10.1016/j.ejmech.2017.12.095 ·PMID:29335207

We investigated a series of uracil analogues by introducing various substituents on the phenyl ring of the N-3 aminoethyl side chain and evaluated their antagonistic activity against human gonadotropin-releasing hormone (GnRH) receptors. An…

article 2001
doi:10.1016/s0223-5234(01)01262-4 ·PMID:11600235

Two series of compounds, benzyl alkylated at position 17alpha and 20 of androstane and pregnane, respectively, were synthesised and tested for steroid sulphatase inhibition. We compared the ability of the compounds to inhibit steroid sulpha…